Upadacitinib Is Effective in Treating Psoriasis Combined with Lichen Planus: A Case Report

    April 2026 in “ Frontiers in Medicine ”
    Xingmo Li, Jinxu Qi, Liping Shi … Qing Zhu
    Studysummary In this case report, a female patient with both psoriasis and lichen planus initially responded to acitretin and topical mometasone but experienced a relapse after stopping the treatment. The authors reported marked improvement within 3 months after switching to upadacitinib, aiming to guide clinical decision-making.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on public-pages-files-2025.frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Jak-Inhibitors Beyond The Label: Emerging Applications In Dermatology Medicina · 2026
    2. Case Report: Psoriasiform Eczema with Immune-Mediated Comorbidities Treated with Upadacitinib Frontiers in Immunology · 2024
    3. Novel Advances of Histone Modification in Inflammatory Skin Diseases and Related Treatment Methods Frontiers in immunology · 2024